Hospitals around the world start COVID-19 treatment rollout

As the world struggles to create a COVID-19 vaccine, some hospitals around the globe are rolling out treatment methods.

One of the most common treatment regimen for COVID-19 patients is providing them with traditional flu medications. Since there is no cure for the actual virus, medical experts are focusing instead on easing the symptoms.

Patients affected by the virus endure flu-like symptoms. In fact, COVID-19 and traditional flu are just different strains coronaviruses. Hospitals around the world are giving their patients the antiviral drug remdesivir as treatment.

Japan approves remdesivir

Many medical experts have shown their support towards the anti-viral drug remdesivir. The drug have been the subject of numerous clinical trials, most of which produce positive results. However, experts warn that remdesivir is not an actual cure.

The Japanese government recently give its approval for the use of remdesivir as treatment against coronavirus. The government claims that through a number of clinical trials, they have proven the efficacy of the drug.

This makes Japan the second country to approve remdesivir as treatment against COVID-19. Japanese medical experts said that the drug will be administered only to patients who are showing severe cases of infection.

In a statement, A Japanese health, labor and welfare official said:

“Remdesivir was approved under exceptional measures. It was our country’s first such approval for the treatment of coronavirus patients.”

Japanese Prime Minister Shinzo Abe confirms that the country is in negotiation with U.S. drug manufacturer Gilead Sciences. Additionally, the country is working a deal with the company to provide remdesivir.

Hydroxychloroquine is another possible candidate for treating COVID-19. However, initial clinical trials reveal that it might do more harm than good.

Llama cells could provide COVID-19 cure

In a wave of good news, medical scientists are turning their attention towards a newly identified particle from a llama named Winter. Scientists from Belgium and the United States are looking for possible antibodies from a llama.

The group is working on a project to combat the spread of coronaviruses like SARS and MERS. According to the scientists, llamas have a unique way of creating antibodies. These are called nanobodies, and that smaller fragments of an antibody.

This is not the first project to study the effects of nanobodies and their capabilities of defeating viruses such as COVID-19. In 2018, Sanofi paid $4.23 billion in order to acquire Ablynx, a company specializing in nanobodies research.

Image courtesy of Dimitri Karastelev/Unsplash

Micky is a news site and does not provide trading, investing, or other financial advice. By using this website, you affirm that you have read and agree to abide by our Terms and Conditions.
Micky readers - you can get a 10% discount on trading fees on FTX and Binance when you sign up using the links above.